Skip to main content
SpringerLink
Log in

Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Taylor DCA, Pandya A, Thompson D, Chu P, Graff J, Drummond M, LaRosa JC, Grundy SM, Shepherd J, Wenger NK.Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80mg versus 10mg in secondary cardiovascular prevention in the UK. Atherosclerosis 7 (Suppl.): 121, No. 3, Jun 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK,. Pharmacoecon. Outcomes News 511, 4 (2006). https://doi.org/10.2165/00151234-200605110-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605110-00009

Keywords

Search

Navigation